EUVIMEDEUVIMED entdecken
Kohortenstudie

Treatment Outcomes of Surgery and ICI Therapy in 52 Patients With Esophageal Melanoma: A Retrospective Single‐Center Cohort Study

Akihiro Ishiguro iD, Dai Ogata iD, Koshiro Ishiyama, Junya Oguma, Daisuke Kurita, Eiji Nakano iD, Kenjiro Namikawa iD, Akira Takahashi, Hiroyuki Daiko, Yasuyuki Seto, Naoya Yamazaki iD

The Journal of Dermatology · 2026

DOI: 10.1111/1346-8138.70097 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift The Journal of Dermatology, 2026. Verfasst von Akihiro Ishiguro und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatologic Oncology, National Cancer Center Hospital, Tokyo, Japan. Hauptthemen laut MEDLINE: Melanoma, Esophageal Neoplasms, Immune Checkpoint Inhibitors, Neoplasm Recurrence, Local. Die Arbeit nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Primary malignant melanoma of the esophagus (PMME) accounts for only 0.5% of all melanomas but is associated with the shortest interval to disease progression and the highest metastasis rate. The optimal treatment for PMME remains elusive. The present study aimed to assess the utility of screening as a means of predicting the prognosis of PMME and to determine the efficacy of surgery and immune checkpoint inhibitors (ICIs) against this disease. Fifty‐two patients with PMME treated at the National Cancer Center Hospital in Japan between 2010 and 2023 were enrolled. Survival analysis was performed for (i) patients with PMME ( n = 52); (ii) resectable cases at the initial presentation ( n = 36); and (iii) cases with systemic therapy ( n = 37). The 5‐year overall survival (OS) rate was 45.0%, and the median OS was 55.8 months. The 5‐year OS rate of the patients in whom PMME was detected by screening and those in whom it was diagnosed clinically was 54.7% and 40.1%, respectively ( p = 0.255). The presence of a lymph node metastasis was associated with a significantly higher recurrence and poorer prognosis. The 3‐year RFS rate of the patients at the local and nodal stage was 57.8% and 6.9%, respectively ( p < 0.0001). At surgery, the rate of lymph node metastasis in the recurrence group and the nonrecurrence group was 68% and 10%, respectively ( p = 0.0027). In the patients who received ICI therapy, the 3‐year OS was 33.3%, the median OS was 15.0 months, and the overall response rate was 23.5%. Our findings suggested that ICI therapy may improve survival in patients with advanced PMME. However, further research is warranted to identify both the clinical and molecular predictors of the treatment response as a means of improving patient selection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaEsophageal NeoplasmsImmune Checkpoint InhibitorsNeoplasm Recurrence, LocalHumansMaleFemaleRetrospective StudiesMiddle AgedAgedTreatment OutcomeLymphatic MetastasisPrognosisAged, 80 and overAdultEsophagectomySurvival RateJapanNeoplasm StagingSurvival Analysis

Stichwörter der Autor:innen

Japaneseesophageal melanomaimmunotherapymucosal melanomaprognostic factorsurgery

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Dermatologic Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Department of Dermatology, Tokyo Medical University, Tokyo, Japan.
  • Department of Dermatology, Miyazaki University, Miyazaki, Japan.
  • Department of Esophageal Surgery, National Cancer Center Hospital, Tokyo, Japan.
  • Department of Dermatologic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.

ORCID-Profile: Akihiro Ishiguro, Dai Ogata, Eiji Nakano, Kenjiro Namikawa, Naoya Yamazaki

Zitieren

APA

Ishiguro, A., Ogata, D., Ishiyama, K., Oguma, J., Kurita, D., Nakano, E., Namikawa, K., Takahashi, A., Daiko, H., Seto, Y., & Yamazaki, N. (2026). Treatment Outcomes of Surgery and ICI Therapy in 52 Patients With Esophageal Melanoma: A Retrospective Single‐Center Cohort Study. The Journal of Dermatology. https://doi.org/10.1111/1346-8138.70097

Vancouver

Ishiguro A, Ogata D, Ishiyama K, Oguma J, Kurita D, Nakano E, et al. Treatment Outcomes of Surgery and ICI Therapy in 52 Patients With Esophageal Melanoma: A Retrospective Single‐Center Cohort Study. The Journal of Dermatology. 2026. doi:10.1111/1346-8138.70097

BibTeX
@article{Ishiguro2026,
  author = {Ishiguro, Akihiro and Ogata, Dai and Ishiyama, Koshiro and Oguma, Junya and Kurita, Daisuke and Nakano, Eiji and Namikawa, Kenjiro and Takahashi, Akira and Daiko, Hiroyuki and Seto, Yasuyuki and Yamazaki, Naoya},
  title = {Treatment Outcomes of Surgery and ICI Therapy in 52 Patients With Esophageal Melanoma: A Retrospective Single‐Center Cohort Study},
  journal = {The Journal of Dermatology},
  year = {2026},
  doi = {10.1111/1346-8138.70097}
}
Kostenlos starten →